Renaissance Technologies - NYMOX PHARMACEUTICAL CORP ownership

Back to all holdings Add to watchlist

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 32 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2014$139,000
-4.1%
28,000
+5.6%
0.00%–
Q1 2014$145,000
-44.9%
26,506
-38.8%
0.00%
-100.0%
Q4 2013$263,000
+11.9%
43,300
+22.0%
0.00%0.0%
Q3 2013$235,000–35,500–0.00%–
 Download
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2013
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 200,190$657,0000.03%
WMS Partners, LLC 65,555$215,0000.03%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders